(Q36031633)

11 August 2017

1 reference

title

Ploidy in gynaecological cancers (English)

1 reference

11 August 2017

Fox H

1

1 reference

11 August 2017

publication date

1 February 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

46

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

121-129

1 reference

A prospective comparison of DNA quantitation by image and flow cytometry.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

DNA index by flow cytometric analysis: an additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Flow cytometric analysis of DNA content in human ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Loss of oestrogen receptor beta, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

DNA content of ovarian immature teratomas and malignant germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

DNA content and proliferative activity in ovarian small cell carcinomas of the hypercalcemic type. Implications for diagnosis, prognosis, and histogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Preoperative evaluation of tumor ploidy in endometrial carcinoma: An accurate tool to identify patients at risk for extrauterine disease and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Prospective Multicenter Validation Confirms the Prognostic Superiority of the Endometrial Carcinoma Prognostic Index in International Federation of Gynecology and Obstetrics Stage 1 and 2 Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Prognostic factors in surgical stage I endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Endometrial stromal sarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 17 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Prognostic significance of DNA cytometry in carcinoma of the uterine cervix FIGO stage IB and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Squamous cell carcinoma of the cervix: HPV 16 and DNA ploidy as predictors of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Ploidy analysis of products of conception by image and flow cytometry with cytogenetic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Hydatidiform moles: DNA flow cytometry, image analysis and selected topics in molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Flow cytometric and clinicopathologic study of complete hydatidiform moles with special reference to the significance of cytometric aneuploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Placental site trophoblastic tumor. Report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2005.02087.X

10.1111/J.1365-2559.2005.02087.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference